CHI3L1 and neoplasm: With tumours that show high-level CHI3L1/Chil1 expression, its inhibition may well counteract its tumorigenic properties and be therapeutic; however, duration of such treatment would need to be carefully evaluated to avoid loss of any protection CHI3L1/Chil1 affords.